Solid Tumor Testing Market in the US 2018-2022

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING

• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY TECHNOLOGY

• Segmentation by technology
• Comparison by technology
• Conventional testing – Market size and forecast 2017-2022
• Non-conventional testing – Market size and forecast 2017-2022
• Market opportunity by technology

PART 08: CUSTOMER LANDSCAPE

PART 09: SEGMENTATION BY END-USER

• Segmentation by end-user
• Comparison by end-user
• Hospitals – Market size and forecast 2017-2022
• Diagnostic laboratories – Market size and forecast 2017-2022
• Academic and research institutes – Market size and forecast 2017-2022
• Market opportunity by end-user

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 12: MARKET TRENDS

• Adoption of NGS in cancer diagnostics
• Preference for liquid biopsy over traditional biopsy
• Increase in investment in cancer research

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies
• Becton, Dickinson and Company
• Danaher
• F. Hoffmann-La Roche
• Illumina
• Thermo Fisher Scientific

PART 15: APPENDIX

• List of abbreviations